Matrix metalloproteinase-1 polymorphism is associated with persistent airway obstruction in asthma in the Taiwanese population

Chien Da Huang, Shu Min Lin, Po Jui Chang, Wen Te Liu, Chun Hua Wang, Chien Ying Liu, Horng Chyuan Lin, Ling Ling Hsieh, Han Pin Kuo

研究成果: 雜誌貢獻文章

8 引文 (Scopus)

摘要

Background and objective: Overexpression of matrix metalloproteinase (MMP)-1 has been demonstrated in asthma, and MMP polymorphisms are known to enhance disease susceptibility. We investigated whether MMP-1 polymorphism is associated with persistent airway obstruction in asthma in the Taiwanese population. Methods: A total of 131 unrelated Taiwanese subjects were enrolled, age-matched, and divided as follows: (1) those who had asthma with persistent airway obstruction with forced expiratory volume in 1 second (FEV1) and FEV1/forced vital capacity (FVC) values less than 75% predicted (n = 41); (2) those with asthma without airway obstruction with FEV1 and FEV1/FVC values <75% predicted (n = 47); and (3) normal control subjects (n = 43). All were genotyped for the 1G/2G polymorphism of MMP-1 promoter (-1607bp). Results: 1G genotypes of MMP-1 containing at least one 1G allele were found in asthmatic patients with persistent airway obstruction (OR = 3.696, 95% CI: 1.489-9.173, p = 0.027), but not in asthmatic patients without airway obstruction (OR = 2.065, 95% CI: 0.890-4.790, p = 0.091) when compared with homozygous 2G (2G/2G). The heterozygous 1G genotype (1G/2G) was more associated with persistent airway obstruction than homozygous 2G (2G/2G) (OR: 4.727, 95% CI: 1.759-12.703, p = 0.012). The adjusted risk estimate of 1G genotypes for asthmatics with persistent airway obstruction was 4.416 (95% CI: 1.651-11.812, p = 0.003). Conclusion: 1G genotypes of MMP-1 polymorphism are associated with asthma with persistent airway obstruction, and the heterozygous 1G genotype (1G/2G) poses the most susceptibility to persistent airway obstruction in asthma.
原文英語
頁(從 - 到)41-46
頁數6
期刊Journal of Asthma
46
發行號1
DOIs
出版狀態已發佈 - 二月 2009
對外發佈Yes

指紋

Matrix Metalloproteinase 1
Airway Obstruction
Asthma
Forced Expiratory Volume
Population
Genotype
Vital Capacity
Disease Susceptibility
Matrix Metalloproteinases
Alleles

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Immunology and Allergy
  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)

引用此文

Matrix metalloproteinase-1 polymorphism is associated with persistent airway obstruction in asthma in the Taiwanese population. / Huang, Chien Da; Lin, Shu Min; Chang, Po Jui; Liu, Wen Te; Wang, Chun Hua; Liu, Chien Ying; Lin, Horng Chyuan; Hsieh, Ling Ling; Kuo, Han Pin.

於: Journal of Asthma, 卷 46, 編號 1, 02.2009, p. 41-46.

研究成果: 雜誌貢獻文章

Huang, Chien Da ; Lin, Shu Min ; Chang, Po Jui ; Liu, Wen Te ; Wang, Chun Hua ; Liu, Chien Ying ; Lin, Horng Chyuan ; Hsieh, Ling Ling ; Kuo, Han Pin. / Matrix metalloproteinase-1 polymorphism is associated with persistent airway obstruction in asthma in the Taiwanese population. 於: Journal of Asthma. 2009 ; 卷 46, 編號 1. 頁 41-46.
@article{4ac439da03ff457eb736cf610bc3e77d,
title = "Matrix metalloproteinase-1 polymorphism is associated with persistent airway obstruction in asthma in the Taiwanese population",
abstract = "Background and objective: Overexpression of matrix metalloproteinase (MMP)-1 has been demonstrated in asthma, and MMP polymorphisms are known to enhance disease susceptibility. We investigated whether MMP-1 polymorphism is associated with persistent airway obstruction in asthma in the Taiwanese population. Methods: A total of 131 unrelated Taiwanese subjects were enrolled, age-matched, and divided as follows: (1) those who had asthma with persistent airway obstruction with forced expiratory volume in 1 second (FEV1) and FEV1/forced vital capacity (FVC) values less than 75{\%} predicted (n = 41); (2) those with asthma without airway obstruction with FEV1 and FEV1/FVC values <75{\%} predicted (n = 47); and (3) normal control subjects (n = 43). All were genotyped for the 1G/2G polymorphism of MMP-1 promoter (-1607bp). Results: 1G genotypes of MMP-1 containing at least one 1G allele were found in asthmatic patients with persistent airway obstruction (OR = 3.696, 95{\%} CI: 1.489-9.173, p = 0.027), but not in asthmatic patients without airway obstruction (OR = 2.065, 95{\%} CI: 0.890-4.790, p = 0.091) when compared with homozygous 2G (2G/2G). The heterozygous 1G genotype (1G/2G) was more associated with persistent airway obstruction than homozygous 2G (2G/2G) (OR: 4.727, 95{\%} CI: 1.759-12.703, p = 0.012). The adjusted risk estimate of 1G genotypes for asthmatics with persistent airway obstruction was 4.416 (95{\%} CI: 1.651-11.812, p = 0.003). Conclusion: 1G genotypes of MMP-1 polymorphism are associated with asthma with persistent airway obstruction, and the heterozygous 1G genotype (1G/2G) poses the most susceptibility to persistent airway obstruction in asthma.",
keywords = "Asthma, MMP-1, Persistent airway obstruction, Polymorphism, Taiwan",
author = "Huang, {Chien Da} and Lin, {Shu Min} and Chang, {Po Jui} and Liu, {Wen Te} and Wang, {Chun Hua} and Liu, {Chien Ying} and Lin, {Horng Chyuan} and Hsieh, {Ling Ling} and Kuo, {Han Pin}",
year = "2009",
month = "2",
doi = "10.1080/02770900802252077",
language = "English",
volume = "46",
pages = "41--46",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Matrix metalloproteinase-1 polymorphism is associated with persistent airway obstruction in asthma in the Taiwanese population

AU - Huang, Chien Da

AU - Lin, Shu Min

AU - Chang, Po Jui

AU - Liu, Wen Te

AU - Wang, Chun Hua

AU - Liu, Chien Ying

AU - Lin, Horng Chyuan

AU - Hsieh, Ling Ling

AU - Kuo, Han Pin

PY - 2009/2

Y1 - 2009/2

N2 - Background and objective: Overexpression of matrix metalloproteinase (MMP)-1 has been demonstrated in asthma, and MMP polymorphisms are known to enhance disease susceptibility. We investigated whether MMP-1 polymorphism is associated with persistent airway obstruction in asthma in the Taiwanese population. Methods: A total of 131 unrelated Taiwanese subjects were enrolled, age-matched, and divided as follows: (1) those who had asthma with persistent airway obstruction with forced expiratory volume in 1 second (FEV1) and FEV1/forced vital capacity (FVC) values less than 75% predicted (n = 41); (2) those with asthma without airway obstruction with FEV1 and FEV1/FVC values <75% predicted (n = 47); and (3) normal control subjects (n = 43). All were genotyped for the 1G/2G polymorphism of MMP-1 promoter (-1607bp). Results: 1G genotypes of MMP-1 containing at least one 1G allele were found in asthmatic patients with persistent airway obstruction (OR = 3.696, 95% CI: 1.489-9.173, p = 0.027), but not in asthmatic patients without airway obstruction (OR = 2.065, 95% CI: 0.890-4.790, p = 0.091) when compared with homozygous 2G (2G/2G). The heterozygous 1G genotype (1G/2G) was more associated with persistent airway obstruction than homozygous 2G (2G/2G) (OR: 4.727, 95% CI: 1.759-12.703, p = 0.012). The adjusted risk estimate of 1G genotypes for asthmatics with persistent airway obstruction was 4.416 (95% CI: 1.651-11.812, p = 0.003). Conclusion: 1G genotypes of MMP-1 polymorphism are associated with asthma with persistent airway obstruction, and the heterozygous 1G genotype (1G/2G) poses the most susceptibility to persistent airway obstruction in asthma.

AB - Background and objective: Overexpression of matrix metalloproteinase (MMP)-1 has been demonstrated in asthma, and MMP polymorphisms are known to enhance disease susceptibility. We investigated whether MMP-1 polymorphism is associated with persistent airway obstruction in asthma in the Taiwanese population. Methods: A total of 131 unrelated Taiwanese subjects were enrolled, age-matched, and divided as follows: (1) those who had asthma with persistent airway obstruction with forced expiratory volume in 1 second (FEV1) and FEV1/forced vital capacity (FVC) values less than 75% predicted (n = 41); (2) those with asthma without airway obstruction with FEV1 and FEV1/FVC values <75% predicted (n = 47); and (3) normal control subjects (n = 43). All were genotyped for the 1G/2G polymorphism of MMP-1 promoter (-1607bp). Results: 1G genotypes of MMP-1 containing at least one 1G allele were found in asthmatic patients with persistent airway obstruction (OR = 3.696, 95% CI: 1.489-9.173, p = 0.027), but not in asthmatic patients without airway obstruction (OR = 2.065, 95% CI: 0.890-4.790, p = 0.091) when compared with homozygous 2G (2G/2G). The heterozygous 1G genotype (1G/2G) was more associated with persistent airway obstruction than homozygous 2G (2G/2G) (OR: 4.727, 95% CI: 1.759-12.703, p = 0.012). The adjusted risk estimate of 1G genotypes for asthmatics with persistent airway obstruction was 4.416 (95% CI: 1.651-11.812, p = 0.003). Conclusion: 1G genotypes of MMP-1 polymorphism are associated with asthma with persistent airway obstruction, and the heterozygous 1G genotype (1G/2G) poses the most susceptibility to persistent airway obstruction in asthma.

KW - Asthma

KW - MMP-1

KW - Persistent airway obstruction

KW - Polymorphism

KW - Taiwan

UR - http://www.scopus.com/inward/record.url?scp=60549114238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549114238&partnerID=8YFLogxK

U2 - 10.1080/02770900802252077

DO - 10.1080/02770900802252077

M3 - Article

C2 - 19191136

AN - SCOPUS:60549114238

VL - 46

SP - 41

EP - 46

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

IS - 1

ER -